Case Studies On Opioid-Related Crimes
1. United States v. Purdue Pharma (OxyContin Case) – 2007/2020
Background:
Purdue Pharma, the maker of OxyContin, was accused of misleading doctors and patients about the addictive potential of their prescription opioids, contributing to widespread opioid abuse in the U.S.
Crime:
False marketing claims
Violating the Controlled Substances Act (CSA) by promoting opioids without adequate warnings
Contributing to illegal distribution indirectly by encouraging overprescription
Case Law/Outcome:
In 2007, Purdue and three executives pleaded guilty to federal charges of misbranding OxyContin as less addictive. They paid over $600 million in fines.
In 2020, Purdue Pharma filed for bankruptcy, and a settlement plan was approved where billions were allocated to state and local governments to address opioid misuse.
Legal Principle:
Companies can be criminally liable for misrepresentation in drug marketing that leads to public health crises. Misbranding under federal law constitutes a criminal offense even without direct intent to cause harm.
2. United States v. Jesse Ross (2018) – Pill Mill Doctor Case
Background:
Dr. Jesse Ross, a licensed physician in Florida, operated what was called a “pill mill,” prescribing large amounts of opioids with little medical justification.
Crime:
Violations of the Controlled Substances Act (illegal distribution)
Fraudulent medical practices
Conspiracy to distribute opioids
Case Law/Outcome:
Ross was convicted on federal charges and sentenced to 20 years in prison.
Courts emphasized that reckless prescribing of opioids, without proper medical oversight, is equivalent to illegal drug distribution.
Legal Principle:
Doctors can face criminal liability if prescribing opioids outside accepted medical standards. The CSA makes it clear that a “medical exception” does not protect practitioners who act recklessly or with disregard for patient safety.
3. United States v. Eric C. DuBose (2017)
Background:
DuBose operated an online pharmacy that shipped opioids to patients across the U.S. without proper prescriptions or medical evaluations.
Crime:
Illegal distribution of controlled substances (opioids)
Mail fraud and conspiracy
Violations of both federal CSA and Food, Drug, and Cosmetic Act
Case Law/Outcome:
Convicted on multiple counts and sentenced to 25 years in federal prison.
The court highlighted the danger of online pharmacies and unverified prescriptions as a modern conduit for opioid crimes.
Legal Principle:
Distribution through online platforms without verification constitutes trafficking. Courts treat this as seriously as street-level drug trafficking.
4. State of New York v. Endo Pharmaceuticals (2019)
Background:
Endo Pharmaceuticals, maker of several prescription opioids, was investigated for promoting opioids for off-label uses without adequate warnings about addiction risk.
Crime:
Misleading marketing
Failing to report known risks of opioids (fraud and public health violations)
Case Law/Outcome:
Endo agreed to a $50 million settlement with New York state.
The settlement required new reporting practices, physician education programs, and restrictions on marketing.
Legal Principle:
Even if not criminally convicted, pharmaceutical companies can face civil liability and state penalties for promoting opioids in ways that contribute to public health harm.
5. United States v. Kenneth Wright (2016) – Opioid Trafficking
Background:
Kenneth Wright was caught running a local opioid trafficking ring, distributing prescription opioids like oxycodone to multiple individuals illegally.
Crime:
Trafficking controlled substances (Schedule II opioids)
Conspiracy to distribute opioids
Possession with intent to distribute
Case Law/Outcome:
Wright was convicted under federal law and sentenced to life imprisonment due to the scale of distribution and prior criminal history.
Legal Principle:
Large-scale trafficking of opioids is treated as a serious federal offense, often carrying life sentences under the CSA, especially when combined with conspiracy and prior criminal conduct.
6. United States v. Mark A. Purdue (2010) – Prescription Forgery Case
Background:
Mark Purdue, a pharmacy technician, was caught forging prescriptions for oxycodone and selling them to street dealers.
Crime:
Forgery of controlled substance prescriptions
Conspiracy to distribute opioids
Possession with intent to distribute
Case Law/Outcome:
Convicted on all counts and sentenced to 15 years federal prison.
This case illustrates that not only doctors or pharmaceutical companies, but also intermediaries like technicians, can face serious penalties.
Legal Principle:
Forgery or falsification of prescriptions constitutes a criminal act under the CSA, even if the forged prescription is technically for a legitimate drug.
Key Takeaways Across These Cases
Doctors, pharmacists, and companies can all face criminal liability for opioid-related misconduct.
Scale and intent matter: large-scale distribution or reckless practices carry heavier penalties.
Misrepresentation of opioid risks is actionable both criminally and civilly.
Federal law (Controlled Substances Act) provides strict liability for improper prescribing, distribution, or marketing.
Online and technological channels are increasingly targeted by law enforcement for opioid-related crimes.
RELATED Blog
comments